Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M112,521Revenue $M15,879Net Margin (%)14.0Altman Z-Score6.1
Enterprise Value $M110,946EPS $1.2Operating Margin %18.4Piotroski F-Score6
P/E(ttm)50.1Beneish M-Score-2.3Pre-tax Margin (%)17.7Higher ROA y-yN
Price/Book7.210-y EBITDA Growth Rate %-1.4Quick Ratio1.8Cash flow > EarningsY
Price/Sales7.05-y EBITDA Growth Rate %-14.3Current Ratio1.9Lower Leverage y-yN
Price/Free Cash Flow43.0y-y EBITDA Growth Rate %-15.4ROA % (ttm)6.7Higher Current Ratio y-yY
Dividend Yield %2.2PEG--ROE % (ttm)14.8Less Shares Outstanding y-yN
Payout Ratio %108Shares Outstanding M1,667ROIC % (ttm)9.0Gross Margin Increase y-yY

Gurus Latest Trades with BMY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMYVanguard Health Care Fund 2015-03-31 Add0.53%$58.48 - $68.47
($62.6)
$ 67.508%Add 9.85%42,902,031
BMYBrian Rogers 2015-03-31 Reduce-0.09%$58.48 - $68.47
($62.6)
$ 67.508%Reduce 7.18%5,814,800
BMYDodge & Cox 2015-03-31 Reduce$58.48 - $68.47
($62.6)
$ 67.508%Reduce 3.52%87,828
BMYKen Fisher 2015-03-31 Add$58.48 - $68.47
($62.6)
$ 67.508%Add 5.54%32,441
BMYMario Gabelli 2015-03-31 Reduce$58.48 - $68.47
($62.6)
$ 67.508%Reduce 0.75%704,425
BMYRonald Muhlenkamp 2015-03-31 Reduce$58.48 - $68.47
($62.6)
$ 67.508%Reduce 0.06%212,170
BMYVanguard Health Care Fund 2014-12-31 Add0.08%$48.92 - $61.3
($56.49)
$ 67.5019%Add 1.50%39,056,361
BMYKahn Brothers 2014-12-31 Add0.01%$48.92 - $61.3
($56.49)
$ 67.5019%Add 2.71%28,400
BMYRuane Cunniff 2014-12-31 Buy $48.92 - $61.3
($56.53)
$ 67.5019%New holding3,670
BMYKen Fisher 2014-12-31 Reduce$48.92 - $61.3
($56.42)
$ 67.5020%Reduce 39.96%30,739
BMYRonald Muhlenkamp 2014-12-31 Reduce$48.92 - $61.3
($56.49)
$ 67.5019%Reduce 0.09%212,290
BMYDodge & Cox 2014-12-31 Add$48.92 - $61.3
($56.49)
$ 67.5019%Add 0.66%91,028
BMYMario Gabelli 2014-12-31 Add$48.92 - $61.3
($56.49)
$ 67.5019%Add 1.35%709,715
BMYVanguard Health Care Fund 2014-09-30 Add0.3%$47.86 - $51.96
($49.97)
$ 67.5035%Add 6.31%38,480,761
BMYJoel Greenblatt 2014-09-30 Sold Out -0.05%$47.86 - $51.96
($49.97)
$ 67.5035%Sold Out0
BMYVanguard Health Care Fund 2014-06-30 Add0.86%$46.59 - $52.19
($49.29)
$ 67.5037%Add 22.96%36,197,961
BMYJoel Greenblatt 2014-06-30 Buy 0.05%$46.59 - $52.19
($49.29)
$ 67.5037%New holding89,363
BMYKen Fisher 2014-06-30 Add$46.59 - $52.19
($49.29)
$ 67.5037%Add 216.10%49,732
BMYRonald Muhlenkamp 2014-03-31 Buy 1.9%$48.54 - $56.61
($53.23)
$ 67.5027%New holding212,015
BMYVanguard Health Care Fund 2014-03-31 Add0.73%$48.54 - $56.61
($53.21)
$ 67.5027%Add 20.35%29,437,761
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Caldarella Joseph CSVP & Controller 2015-06-04Sell16,972$65.713.39view
Schmukler Louis SPres., Global Mfg. & Supply 2015-03-16Sell12,000$66.961.46view
Cuss Francis MEVP & CSO 2015-03-16Sell114,666$67.810.19view
Moed Samuel JSVP, Strat Plan & Analysis 2015-03-13Sell591$66.671.9view
Moed Samuel JSVP, Strat Plan & Analysis 2015-03-10Sell10,343$65.843.19view
Elicker John ESVP Pub Affairs & Inv Relation 2015-03-06Sell10,468$66.242.57view
LEUNG SANDRAGeneral Counsel & Secretary 2015-02-17Sell11,746$60.3912.5view
Moed Samuel JSVP, Strat Plan & Analysis 2015-02-12Sell3,880$59.2614.65view
Moed Samuel JSVP, Strat Plan & Analysis 2015-02-06Sell21,478$60.1512.95view
CORNELIUS JAMES MDirector 2015-01-30Sell50,000$60.612.11view

Quarterly/Annual Reports about BMY:

News about BMY:

Articles On GuruFocus.com
Will Bill Ackman Go After Express Scripts Next? Jun 30 2015 
Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
gild Jun 02 2015 
Abbvie Inc. Dividend Stock Analysis May 26 2015 
Baxter Takes The Acquisition Route To Grow In The Oncology Segment May 14 2015 
Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio May 07 2015 
Vanguard Adds to Four of Its Largest Stakes May 04 2015 
HealthCare Stocks That Can Make Investors Healthier Apr 08 2015 
Bristol-Myers Signs An Exclusive Pact In Gene Therapy For Treating Cardiovascular Disorders Apr 08 2015 
Piper Jaffray Sees Potential in uniQure NV (QURE) and Bristol-Myers Squibb (BMY) Collaboration Apr 07 2015 

More From Other Websites
Celgene bet $1 billion that this biotech’s science can cure deadly cancers Jun 30 2015
Why is Celgene So Darn Expensive? Jun 30 2015
Your first trade for Tuesday, June 30 Jun 29 2015
Alexandria Reveals 15-Year Anchor Lease with Bristol-Myers - Analyst Blog Jun 29 2015
Buy Sysco Foods, Bristol-Myers Now Before Their Dividend Payouts Jun 29 2015
Bristol-Myers Announces Job Cuts, Changes in R&D Sites - Analyst Blog Jun 26 2015
Is Big Pharma Advertising Getting Out of Control? Jun 26 2015
Bristol-Myers Squibb's new R&D site will be about as big as Baxter's Jun 26 2015
Alexandria Real Estate Equities, Inc. Announces 15-Year Anchor Lease of 208,000 RSF with... Jun 26 2015
Alexandria Real Estate Equities, Inc. Announces 15-Year Anchor Lease of 208,000 RSF with... Jun 26 2015
Bristol-Myers Squibb to open Cambridge R&D center Jun 25 2015
Bristol-Myers Squibb to shift research jobs Jun 25 2015
5 Huge Stocks to Trade for Huge Gains -- Must-See Charts Jun 25 2015
Bristol-Myers to Close Sites, Cut 100 Jobs Jun 25 2015
Bristol-Myers to close sites, cut 100 jobs Jun 25 2015
Bristol-Myers to stop new antiviral drug research Jun 25 2015
Bristol-Myers Halts Virus-Drug Research, Cuts 100 Employees Jun 25 2015
Lilly Blooms; Shares Up 4.5% on Patent Win, Merrill Upgrade Jun 25 2015
Bristol-Myers Squibb Expands R&D Presence Within Hubs of World Class Science and Innovation Jun 25 2015
Bristol-Myers Squibb Expands R&D Presence Within Hubs of World Class Science and Innovation Jun 25 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK